Aimei Health Technology Co Unit

AFJKU

Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.

NEW YORK , July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating AlphaTime Acquisition Corp. (NASDAQ: ATMCR ) related to its merger with HCYC Holding Co., in which AlphaTime shares will be cancelled in exchange for the right to receive a Class A share of HCYC Holding Company.

Green energy company United Hydrogen Group said on Thursday it would be listing its shares on the Nasdaq via a blank-check merger that values the company at $1.6 billion.

Shanghai, China, June 20, 2024 (GLOBE NEWSWIRE) -- United Hydrogen Group Inc. (“United Hydrogen” or the “Company”), a comprehensive hydrogen solution company, and Aimei Health Technology Co., Ltd (“AFJK”) (Nasdaq: AFJK, AFJKU, AFJKR), a Cayman Islands special purpose acquisition company, announced that they entered into a definitive business combination agreement (the “Business Combination Agreement”) for a business combination (the “Business Combination”). Upon the consummation of the Business Combination, United Hydrogen will operate through a publicly-traded holding company listed on the Nasdaq Stock Market.

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. (“Aimei”) announced today that, commencing January 22, 2024, holders of the units sold in the Company's initial public offering completed on December 6, 2023 may elect to separately trade the ordinary shares of Aimei, and the rights included in such units on The Nasdaq Global Market (“Nasdaq”).

New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, the “Company”) announced today that it closed its initial public offering of 6,900,000 units at $10.00 per unit, including the full exercise of the underwriters' option to purchase up to an additional 900,000 units to cover over-allotments. Each unit consists of one ordinary share and one right. Each right entitles the holder thereof to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination.